Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective Study of the Natural History of Patients With Type 2 and 3 Spinal Muscular Atrophy

NCT02391831 is registered in ClinicalTrials.gov with Institut de Myologie, France as lead sponsor.

NCT NCT02391831
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02391831 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective Study of the Natural History of Patients With Type 2 and 3 Spinal Muscular Atrophy
Lead sponsor
Institut de Myologie, France
Phase
Not applicable
Overall status
Completed
Start date
May 31, 2015
Completion date
June 30, 2018
Enrollment
81 (actual)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

type 2 spinal muscular atrophy, type 3 spinal muscular atrophy